Clinical Trial Update: Glitazones and Endothelial Function (GATE) [Phase 3]

View source ↗

Summary

Phase 3 trial GATE evaluating glitazones and endothelial function in type 2 diabetes mellitus was terminated. The snippet does not provide trial results or reas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• Avandia (rosiglitazone)

Snippet

Sponsor: University of Calgary | Conditions: Diabetes Mellitus | Phase 3 | Status: TERMINATED